Study Finds Stereotactic Radiotherapy Promising for Localized Prostate Cancer

New research findings suggest that stereotactic radiotherapy may offer effectiveness comparable to conventional surgery in controlling localized prostate cancer, with potentially fewer treatment-related side effects.

Researchers presenting at the latest meeting of the American Society for Radiation Oncology reported that an eight-year follow-up of 123 patients enrolled in the trial found disease control without tumor recurrence in 91% of cases, compared with 84% among patients who underwent surgery.

Stereotactic radiotherapy uses precisely targeted, concentrated radiation doses directed at the prostate gland, aiming to destroy cancer cells while minimizing radiation exposure to surrounding healthy tissues.

The findings highlight the potential role of stereotactic radiotherapy as a treatment option for localized prostate cancer. However, the most appropriate approach depends on individual patient characteristics, tumor features and the potential risks and side effects of each treatment.